Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

4.40
Delayed Data
As of 3:58pm ET
 0.00 / 0.00%
Today’s Change
2.26
Today|||52-Week Range
5.09
-2.22%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close4.40
Today’s open4.44
Day’s range4.35 - 4.63
Volume61,615
Average volume (3 months)159,012
Market cap$202.7M
Dividend yield--
Data as of 3:58pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+78.26%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+1.72%
P/E ratio34.3
Price/Sales1.39
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...+0.02+0.63%
BSTCBiospecifics Technol...+1.38+4.41%
AMRNAmarin Corporation P...+0.03+2.34%
FLXNFlexion Therapeutics...+0.13+1.16%
Data as of 3:58pm ET, 02/10/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$97.6M
Annual profit (last year)-$2.3M
Net profit margin-2.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts

Partner Offers